Remember meForgot password?
    Log in with Twitter

Boehringer Ingelheim News

Op-Ed: Watchdog group takes FDA to task over Pradaxa approval

A watchdog group said on Thursday the FDA was “lax” and “permissive” in its approval of a blood-thinner designed to prevent clots and strokes in patients with a heart condition that affects millions of Americans.

Mix of successes and failures for Big Pharma

It has been a mixed week for the pharmaceutical sector in terms of drug development, with success for Novartis and disappointing news for Boehringer and Vitae Pharma. Digital Journal reports on the latest news.

Bayer facing lawsuits in U.S. over anti-clotting drug Xarelto

The Frankfurter Allgemeine Zeitung news reported on Saturday that Germany's Bayer AG pharmaceutical company will be facing its first lawsuits in the U.S. this year over its anti-clotting drug, Xarelto, one of its top-five money makers.

Search Digital Journal Archives

Set up a news alert for

Boehringer Ingelheim

Boehringer Ingelheim Image

Latest News
Top News